The CFSRE is developing Public Alerts and related reports to increase public awareness regarding NPS involvement in adverse intoxications,...
Reports
The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical examiners...
This report provides up-to-date informatyion regarding the drug supply in Philadelphia, PA.
Federal Register: 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE) in Schedule I
Lisa McElhaney / /With the issuance of this final rule, the Drug Enforcement Administration places 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE), including its salts, isomers, and...
In 2021, the Drug Abuse Warning Network (DAWN) identified 141,529 (unweighted) drug-related emergency department (ED) visits from 52 participating...
The Drug Enforcement Administration’s Toxicology Testing Program (DEA TOX) began in May 2019 as a surveillance program aimed at...
LAPPA recently published a new fact sheet pertaining to Overdose Fatality Review, also known as OFR. OFR is a...
The objective of this report is to provide guidance in developing an appropriate analytical scope of testing for NPS...
NPS Alert: Synthetic Stimulant Market Rapidly Changing as N,N-Dimethylpentylone Replace Eutylone in Drug Supply Typically Sold as “Ecstacy” or “Molly”
Lisa McElhaney / /The objective of this announcement is to notify public health and safety, law enforcement, first responder, clinicians, medical examiners...
This report provides up-to-date information regarding the status of NPS opioid prevalence and positivity within the United States
Trending Reports
- NDEWS Hotspot Alerts May 9 – 15, 2024 May 17, 2024
- csfre: Recommended Scope for NPS Testing in the United States (Q2 – 2024) May 17, 2024
- Notice of Proposed Rulemaking: Schedules of Controlled Substances: Rescheduling of Marijuana May 16, 2024
- DEA National Drug Threat Assessment 2024 May 9, 2024
- Trend Reports: cfsre NPS – Q1 2024 April 13, 2024